Beam Therapeutics Inc (BEAM) PT Raised to $57 at Wedbush
Tweet
Share
E-mailGet Alerts BEAM Hot Sheet
Price: $29.02 -1.39%
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
20 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $57.00 (from $48.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences
- Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
- GDS Holdings (GDS) PT Lowered to $51 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
